AI Image
Tests of Unapproved Weight- Loss Drug Reveal Its Dangers
Newser • • business
Key Points:
- Retatrutide, an obesity drug still under federal safety review, is being sold online and in places like a New York bodega without proper medical oversight, despite warnings that it is for research use only and not for human consumption.
- CBS News testing revealed that online samples contained a basic form of retatrutide, while a bodega-bought vial contained no active drug but harmful contaminants, including bacteria.
- Experts caution that purchasing and using such unregulated drugs poses significant health risks, including infection and serious illness, as regulatory agencies struggle to control the illicit market.
- The FDA has reported two deaths in 2024 linked to illegal retatrutide use, highlighting the dangers of these unapproved products.
- Similar illicit sales of retatrutide are widespread in the UK, with the drug being sold in gyms, salons, and even by street vendors, according to BBC reports.
